|
| ALIDITY
OF NON-INVASIVE DIAGNOSIS IN MORPHOHAEMODYNAMICS OF CONGENITAL
HEART DISEASE |
|
S. Dinarević, R. Terzić, Z. Begić and V. Mulaosmanović |
| Pediatric
Clinic, Clinical Center University of Sarajevo, Bosnia and
Herzegovina |
Transthoracic
echocardiography (TTE) has brought a revolution in pediatric cardiology.
The aim of this study is to evaluate the validity of non-invasive
diagnostics in relation to invasive, and its ability to define
morphology and haemodynamics of congenital heart disease (CHD).
During September 1966 till April 2001 at the Cardiology department
of the Paediatric Clinic in Sarajevo, a group of 90 pts were evaluated
with diagnosed CHD (54% boys). Diagnosis of CHD, except clinical
examination, ECG and X ray has been confirmed by ultrasound (US)
on a "Hewlett Packard" and "Toshiba" SSH165, using 5 MHz and 2,5
MHz Doppler. CHD-s type L-R shunt have been diagnosed in 37 pts
(41,2%), obstructive in 19 (21,1%) and cyanotic in 34 pts (37,7%).
According to US findings, surgical correction has been suggested
and performed in 77 pts; abroad in 89,6% (69 pts), and in 10,4%
(8/77) in Sarajevo. In 44/90 (48,8%) cardiac catheterisation was
done; in 29/44 as diagnostical and in 15/44 as therapeutical tool.
61/90 pts (67,8%) had diagnosis done only by US, and by diagnostic
catheterisation it was completed in 19/90 (32,2%). 46/77 operated
pts (69,7%) had diagnosis done by US; in 30 pts (67,3%) as a simple
CHD and as complex CHD in 16 (32,7%). By comparasion of US findings
and findings from the operating table, the correct US findings
have been in 68/77 (88,4%) pts, and incorrect in 9/77 (11,6%),
proving the significance of non-invasive diagnosis in 79-98% (p=0,001)
of cases. This study shows the validity of TEE in performing the
diagnosis of majority of CHD in relation to invasive diagnosis.
TTE represents the sovereign method of diagnosis of CHD, leaving
the significant minor % (p=0,001) for diagnosis by invasive diagnostics
of morphohaemodynamics of CHD, and at the same time as a chioce
of adequate therapeutical tool in dealing with CHD.
|